Novo Nordisk's Christmas Gift To Shareholders: The Wegovy Pill Has Been Approved [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
The Wegovy pill delivers 16.6% weight loss in 64 weeks, outpacing Eli Lilly's Orforglipron and offering long-term cardiovascular benefits. NVO will enjoy at least 90 days of U.S. market exclusivity, with robust early demand expected due to oral preference and competitive pricing at $149/month. Despite recent share gains, NVO stock trades at a 14x P/E ratio—well below its historical average—implying substantial upside from multiple reversion and growth catalysts. D-Keine/E+ via Getty Images I was losing hope regarding the oral semaglutide (aka Wegovy pill) gaining FDA approval, but the positive outcome came right before Christmas. I personally think this is the turning point for Novo Nordisk A/S ( This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Eli Lilly investors shouldn't sweat rival Novo Nordisk having the first obesity pill on sale [CNBC]CNBC
- US stocks approach records after mixed reports on economic growth, consumer confidence [Yahoo! Finance Canada]Yahoo! Finance Canada
- Stock market today: S&P 500, Nasdaq, Dow turn higher after surprise GDP growth trims rate-cut bets [Yahoo! Finance Canada]Yahoo! Finance Canada
- Novo Nordisk stock surges on hopes Wegovy pill approval will deliver 'redemption' for investors [MSNBC.com]MSNBC.com
- US stocks hold near their records after mixed reports on economic growth, consumer confidence [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website